Gregory Gregoriadis
President at The International Liposome Society
Profile
Gregory Gregoriadis was the founder of Xenetic Biosciences (UK) Ltd.
founded in 1997, where he held the title of Non-Executive Director & Chief Scientific Officer from 2012 to 2014.
He is currently the President of The International Liposome Society since 2003.
Dr. Gregoriadis has previously worked as the Head-Liposomal Therapeutic Group at The Medical Research Council and as an Emeritus Professor at the University of London.
He received his doctorate degree from the University of London in 2001.
Gregory Gregoriadis active positions
| Companies | Position | Start |
|---|---|---|
| The International Liposome Society | President | 2002-12-31 |
Former positions of Gregory Gregoriadis
| Companies | Position | End |
|---|---|---|
Xenetic Biosciences (UK) Ltd.
 Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Founder | 2014-02-09 |
| University of London | Corporate Officer/Principal | - |
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Corporate Officer/Principal | - |
Training of Gregory Gregoriadis
| University of London | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Health Technology |
The Medical Research Council
The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Commercial Services |
| The International Liposome Society | Commercial Services |
- Stock Market
- Insiders
- Gregory Gregoriadis
